The Economics of New Health Technologies: Incentives, organization, and financing
Joan Costa-Font, Christophe Courbage, Alistair McGuire
OUP Oxford, May 14, 2009 - Medical - 312 pages
Technological change in healthcare has led to huge improvements in health services and the health status of populations. It is also pinpointed as the main driver of healthcare expenditure. Although offering remarkable benefits, changes in technology are not free and often entail significant financial, as well as physical or social risks. These need to be balanced out in the setting of government regulations, insurance contracts, and individuals' decisions to use and consume certain technologies. With this in mind, this book addresses the following important objectives: to provide a detailed analysis of what technological change is; to identify drivers of innovation in several healthcare areas; to present existing mechanisms and processes for ensuring and valuing efficiency and development in the use of medical technologies; and to analyse the impact of advances in medical technology on health, healthcare expenditure, and health insurance. Each of the seventeen chapters summarizes an important issue concerning the innovation debate and contributes to a better understanding of the role innovation has both at the macro level and at the delivery (meso) and micro level in the healthcare sector. The effectiveness of innovation in improving people's welfare depends on its diffusion and inception by the relevant agents in the health production process, and this book recognizes the multi-faceted contribution of policy makers, regulators, managers, technicians, consumers and patients to this technology change. This book offers the first truly global economic analysis of healthcare technologies, taking the subject beyond simply economic evaluation, and exploring the behavioural aspects, organization and incentives for new technology developments, and the adoption and diffusion of these technologies.
What people are saying - Write a review
We haven't found any reviews in the usual places.
problem sequences systems and symbiosis
scientific force or powerforce?
Insurance and new technology
Technological changeand health insurance
Genetic advances and health insurance
Ageing and pharmaceutical innovation
The convergence of nano bio and information technologies in healthcare
The limits and challenges tothe economic evaluation of health technologies
Home or nursing home? The effect of medical innovation on the demand for longterm care
Joan CostaFont Caroline Rudisill andElias Mossialos 17 Institutional pathways forintegrating genetic testing into mainstream health care
Other editions - View all
adverse selection analysis andthe behaviour benefits CABG cent chapter characteristics chronic clinical competition condition consumers consumption cost sharing decision demand diabetes diagnostic diffusion disease economic evaluation educational programme effects factors genes genetic information genetic testing glaucoma HCPCS health care expenditure Health Economics health information health insurance health providers health services healthcare higher hip protector home residence rate impact important improvements incentives increase individuals innovation process input institutions insurance coverage interaction Internet interventions inthe investment irreversibility isoquant Journal knowledge marginal cost mechanisms medical innovation Medicare medicine MEPS MODY moral hazard nursing home residence OECD ofhealth ofnew ofthe onthe patient-centred educational patients perspective pharmaceutical innovation physicians population potential prescribing prescription drug private insurance problems procedures QALY response risk sector specific statin surveillance technological change tothe treatment type 2 diabetes variable withthe